Organization
Aptose Biosciences, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Aptose Biosciences, Inc.
... SAN DIEGO and TORONTO, May 17, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. ("Aptose" or the "Company") (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing highly ...
... The Price to Book of 6.9 [1.1]. 17:00 EDT [-1.2%, 21.6%, CAD1,509] Aptose Biosciences underperforms 81% of the market Its MCap is CAD121.3 million (US$94.5 ...
... SAN DIEGO and TORONTO, May 10, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. ("Aptose" or the "Company") (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing highly ...
... An increase is another bullish indicator. 17:00 EDT [0.4%, 17.9%, CAD3,769] Two-bagger Aptose Biosciences increases Its MCap is CAD125.4 million (US$97.1 million) at the last ...
... CANADIAN WEEKLY STOCK REPORT Aptose Biosciences Inc. (TSX:APS), Canada's 13th largest Biotechnology company by market cap, has dropped ...
... on Wednesday, May 2, 2018 at 1:30 p.m. EDT: Source: TMX Group SECTION 1 APTOSE BIOSCIENCES ACTIVITIES Aptose Biosciences Inc. is a clinical stage biotechnology ...
... SAN DIEGO and TORONTO, April 24, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. ("Aptose" or the "Company") (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing highly ...
... Price to Book of 2.7 [5.8]. 17:00 EDT [0.6%, 48.5%, CAD2,590] Three-bagger Aptose Biosciences jumps 8.2% Its MCap is CAD131.9 million (US$103.3 million) at the ...
... CANADIAN RESULTS Aptose Biosciences (TSX:APS) reported loss for the year-ended 31 December 2017 of $US11.7m. Highlights ...
Subscribe now for full coverage on Aptose Biosciences, Inc.
Start My Free Trial